Skip to Content

Join the 'Thyroid Cancer' group to help and get support from people like you.

Thyroid Cancer News

Related terms: Anaplastic thyroid cancer

No Benefit From Routine Thyroid Cancer Screening: Task Force

Posted 15 days ago by Drugs.com

TUESDAY, Nov. 22, 2016 – Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation issued 20 years ago. Thyroid cancer is rare in the United States. In 2016, an estimated 64,300 new cases will be diagnosed, representing 3.8 percent of all new cancers. The thyroid is a small gland in the neck that play a key role in controlling metabolism. "While there is very little evidence of the benefits of screening for thyroid cancer, there is considerable evidence of the significant harms of treatment," said task force member Karina Davidson. She is director of the Center for Behavioral Cardiovascular Health at Columbia University Medical Center in New York City. "And in the places where universal screening has been tried, it hasn't helped people live longer, ... Read more

Related support groups: Cancer, Thyroid Cancer, Diagnosis and Investigation

Scans Not Worthwhile for Most Thyroid Cancers: Study

Posted 21 Jul 2016 by Drugs.com

THURSDAY, July 21, 2016 – Having scans after treatment does not improve thyroid cancer patients' chances of survival, a new study shows. Researchers from the University of Michigan looked at more than 28,000 patients in the United States who were diagnosed with thyroid cancer between 1998 and 2011. After treatment, 57 percent of the patients had at least one ultrasound, 24 percent had a radioiodine scan and 15 percent had a PET scan to monitor for signs of the return of their cancer. Patients who had scans were more likely to undergo further treatment, such as surgery, radioactive iodine treatment or radiation therapy. However, patients who had scans were as likely to die as those who did not have scans, according to the study. "Over time, we have seen this marked increase in the use of imaging after primary treatment of thyroid cancer, despite the fact that the majority of our ... Read more

Related support groups: Thyroid Cancer, Thyroid Tumor, Body Imaging

Thyroid Cancer Cases in U.S. Level Off, Perhaps Reflecting Diagnostic Changes

Posted 15 Apr 2016 by Drugs.com

THURSDAY, April 14, 2016 – Fewer thyroid cancers are diagnosed in the United States now than in the recent past, perhaps signaling a change in physician practices, a new study says. And many thyroid growths won't even be called "cancer" any more, according to another new report. The tripling of thyroid cancer cases over the past 30 years "used to be a mystery," said Dr. Luc Morris, lead author of a report published online April 14 in the journal JAMA Otolaryngology--Head & Neck Surgery. But recently, many researchers attributed the rise largely to technological advances that allow doctors to identify and biopsy small, harmless nodules in the thyroid gland, said Morris. He is a surgical oncologist at Memorial Sloan Kettering Cancer Center in New York City. "Up to 30 percent of healthy persons have small cancers in their thyroid glands, and nearly all of these would not go on to cause ... Read more

Related support groups: Cancer, Thyroid Disease, Hyperthyroidism, Thyroid Cancer, Thyroid Tumor

Surgeons' Experience Matters With Thyroid Removal

Posted 28 Mar 2016 by Drugs.com

FRIDAY, March 25, 2016 – If you need your thyroid gland removed, choosing a surgeon who performs more than 25 thyroid removals a year might minimize your risks, a new study suggests. "This is a very technical operation, and patients should feel empowered to ask their surgeons how many procedures they do each year, on average," said study senior author Dr. Julie Sosa, chief of endocrine surgery at Duke University, in Durham, N.C. "Surgeons have an ethical responsibility to report their case numbers. While this is not a guarantee of a positive outcome, choosing a more experienced surgeon certainly can improve the odds that the patient will do well," Sosa said in a university news release. The thyroid, located at the base of the throat, produces hormones that regulate your metabolism. Thyroid removal (thyroidectomy) is not uncommon and often done due to cancer or enlargement, Sosa and her ... Read more

Related support groups: Surgery, Thyroid Disease, Thyroid Cancer, Head & Neck Surgery, Thyroid Storm, Myxedema Coma, Thyroid Tumor

Agent Orange Linked to Bladder Cancer, Thyroid Problems, Panel Says

Posted 10 Mar 2016 by Drugs.com

THURSDAY, March 10, 2016 – There is stronger evidence of a link between the herbicide Agent Orange and bladder cancer and thyroid problems among U.S. military personnel exposed to the chemical during the Vietnam War, a new Institute of Medicine report shows. However, there is little to no evidence of an association between the birth defect spina bifida and a mother's or father's exposure to Agent Orange, according to the report. The report committee also concluded that military personnel exposed to Agent Orange who have Parkinson's disease-like symptoms can file a claim for the condition. Agent Orange is an herbicide sprayed during the Vietnam War to kill off trees and vegetation that the enemy used as cover. The U.S. military sprayed millions of gallons of Agent Orange and other herbicides during the war. For this report, the authors looked at studies published between Oct. 1, 2012, ... Read more

Related support groups: Parkinson's Disease, Thyroid Cancer, Poisoning, Bladder Cancer, Toxic Reactions Incl Drug and Substance Abuse, Parkinsonian Tremor, Parkinsonism

Thyroid Cancer Survivors: Good Prognosis, Gloomy Outlook?

Posted 30 Dec 2015 by Drugs.com

TUESDAY, Dec. 29, 2015 – Thyroid cancer survivors report lower quality of life than people who survive deadlier cancers, a new study finds. About 98 percent of thyroid cancer patients survive five years and more than 95 percent survive a decade, leading some to call it a "good cancer." Moreover, thyroid cancer, which is on the rise, could soon account for 10 percent of all cancer survivors in the United States, researchers from the University of Chicago Medical Center said. The study included nearly 1,200 thyroid cancer survivors, average age 48, from across the United States and Canada. They were given a questionnaire that assessed their physical, psychological, social and spiritual well-being. The survivors reported an average of 5.5 out of 10 on a quality-of-life scale. This was lower than the average of 6.75 among survivors of colon, breast and other types of cancer that require ... Read more

Related support groups: Thyroid Cancer

Surgeon's Experience Tied to Success of Thyroid Removal: Study

Posted 8 Oct 2015 by Drugs.com

THURSDAY, Oct. 8, 2015 – Patients who undergo thyroid removal may be less likely to suffer complications if their surgeon performs many such surgeries each year, a new study says. Removal of the thyroid gland, located at the base of the neck, is a common operation. More than 72,300 total thyroidectomies are performed in the United States annually, usually to treat thyroid cancer or benign thyroid diseases, the study authors said. The authors examined data from nearly 17,000 American adults who had their thyroid removed between 1998 and 2009. About half these patients had cancer, and the other half had thyroid disease. Overall, 6 percent of the patients had complications after their surgery, such as damage to voice box nerves, excessive bleeding, poor wound healing, breathing or heart problems, hormone deficiency and death. Complication rates were 4 percent among patients whose surgeon ... Read more

Related support groups: Surgery, Thyroid Disease, Hypothyroidism, Underactive Thyroid, Hashimoto's Disease, Hypothyroidism - After Thyroid Removal, Hyperthyroidism, Thyroid Cancer, TSH Suppression, Goiter, Thyroid Suppression Test, Head & Neck Surgery, Graves' Disease, Thyroid Storm, Chronic Lymphocytic Thyroiditis, Myxedema Coma, Thyroid Tumor, Thyrotoxicosis, Myxedema, Thyroid Hemorrhage/Infarction

Better Imaging Scans Catching More Thyroid Cancers: Study

Posted 11 Sep 2015 by Drugs.com

FRIDAY, Sept. 11, 2015 – Advanced imaging technology has helped doctors spot more cases of thyroid cancer over the past decade, a new study finds. But the Mayo Clinic researchers warn that nearly one-third of these cases involve people with low-risk tumors. "We are spotting more cancers, but they are cancers that are not likely to cause harm," study author Dr. Juan Brito Campana, an assistant professor of medicine at the Mayo Clinic in Rochester, Minn., said in a Mayo news release. "Their treatment, however, is likely to cause harm, as most thyroid cancers are treated by surgically removing all or part of the thyroid gland. This is a risky procedure that can damage a patient's vocal cords or leave them with lifelong calcium deficiencies," he said. Treatment for thyroid cancer can also be a financial burden for patients and their families, Brito Campana added. In 2013 alone, the total ... Read more

Related support groups: Cancer, Thyroid Disease, Thyroid Cancer, Head and Neck Cancer, Diagnosis and Investigation, Thyroid Tumor, Body Imaging, Solid Tumors, Head Imaging

Specially Trained Pooch Sniffs Out Thyroid Cancer

Posted 8 Mar 2015 by Drugs.com

FRIDAY, March 6, 2015 – Could a trained "sniffer dog" someday replace costly, invasive techniques used to spot thyroid cancer? That's the promise of an early report on one such canine, a German Shepherd mix named Frankie. A team at the University of Arkansas in Little Rock said that Frankie can accurately sniff out cases of thyroid cancer when presented with patients' urine samples. If this early work pans out, "scent-trained canines could be used by physicians to detect the presence of thyroid cancer at an early stage and to avoid surgery when unwarranted," study senior author Dr. Donald Bodenner said in an Endocrine Society news release. The findings were scheduled for presentation on Friday at the society's annual meeting in San Diego. One expert in thyroid cancer said improvements in spotting the disease are needed. "Currently, if a suspicious thyroid nodule is detected on ... Read more

Related support groups: Thyroid Cancer

Breast Cancer Survivors May Have Higher Thyroid Cancer Risk

Posted 6 Mar 2015 by Drugs.com

FRIDAY, March 6, 2015 – Women who survive breast cancer may have a higher-than-average risk of developing thyroid cancer in the next several years, a new study suggests. Looking at government data on over 700,000 U.S. women treated for breast cancer, researchers found that the women had a higher-than-normal risk of developing thyroid cancer – particularly within five years of the breast cancer diagnosis. The study results suggest that breast cancer survivors should have "vigilant screening" for thyroid cancer in the first five years after their diagnosis, said the study's lead author, Dr. Jennifer Hong Kuo, a surgeon at Columbia University Medical Center in New York City. The study was designed to find an association between breast cancer and the development of thyroid cancer. But, it cannot show whether or not having breast cancer or its treatments caused the increased risk of ... Read more

Related support groups: Breast Cancer, Thyroid Cancer

FDA Approves Lenvima (lenvatinib) for Advanced Thyroid Cancer

Posted 16 Feb 2015 by Drugs.com

FRIDAY, Feb. 13, 2015 – The U.S. Food and Drug Administration on Friday approved a new drug to treat progressive thyroid cancer that continues to worsen despite radioactive iodine therapy. Results of a just-published clinical trial found that the oral drug Lenvima (lenvatinib) delayed progression of the disease almost five times longer than a placebo in people with recurring tumors. Lenvima is a targeted therapy that fights thyroid cancer by deterring the growth of new blood vessels that could help feed the cancer, researchers said. It delayed progression of advanced thyroid cancer by 18 months, compared with four months for patients treated with a placebo, the trial found. Results of the study, which was funded by drug manufacturer Eisai, were published in the Feb. 12 issue of the New England Journal of Medicine. Historically, radioactive iodine has been the only treatment available ... Read more

Related support groups: Thyroid Cancer, Lenvatinib

Lenvima Approved for Common Thyroid Cancer

Posted 15 Feb 2015 by Drugs.com

FRIDAY, Feb. 13, 2015 – Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer (DTC) that has progressed despite radioactive iodine therapy, the agency said Friday in a news release. DTC is the most common type of thyroid cancer, the FDA said. Nearly 63,000 Americans were diagnosed with thyroid cancer in 2014 and about 1,890 died from it, according to the U.S. National Cancer Institute. The thyroid gland is in the neck and helps regulate the body's metabolism. Lenvima is from a class of drugs called kinase inhibitors, which block certain proteins that spur the growth of cancer cells. The drug was clinically evaluated among 392 people with DTC. Those given the new drug lived an average of 18.3 months without cancer progression, compared with 3.6 months among people given a placebo. Lenvima's most common side effects ... Read more

Related support groups: Thyroid Cancer

FDA Approves Lenvima (lenvatinib) for Differentiated Thyroid Cancer

Posted 13 Feb 2015 by Drugs.com

February 13, 2015 – The U.S. Food and Drug Administration today granted approval to Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive iodine therapy (radioactive iodine refractory disease). The most common type of thyroid cancer, DTC is a cancerous growth of the thyroid gland which is located in the neck and helps regulate the body’s metabolism. The National Cancer Institute estimates that 62,980 Americans were diagnosed with thyroid cancer and 1,890 died from the disease in 2014. Lenvima is a kinase inhibitor, which works by blocking certain proteins from helping cancer cells grow and divide. “The development of new therapies to assist patients with refractory disease is of high importance to the FDA,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products ... Read more

Related support groups: Thyroid Cancer

New Drug Lenvatinib May Slow Recurrent Thyroid Cancer, Study Finds

Posted 12 Feb 2015 by Drugs.com

THURSDAY, Feb. 12, 2015 – A new thyroid cancer drug can delay the progression of the disease almost five times longer than a placebo in people with recurring cancer, according to results from a new clinical trial. The oral drug, lenvatinib, is a targeted therapy that fights cancer by deterring the growth of new blood vessels that could help feed the cancer, researchers said. Lenvatinib delayed progression of advanced thyroid cancer by 18 months, compared with four months for patients treated with a placebo, the trial found. "It's an encouraging time for the advancement of treating patients with many different kinds of cancer," said Dr. Gregory Masters, of the new targeted therapies. Masters is an oncologist at Christiana Care Health System in Newark, Del., and a member of the American Society of Clinical Oncology. "We're achieving a greater understanding of the pathways by which these ... Read more

Related support groups: Thyroid Cancer

Kidney and Thyroid Cancer Rates Up Among U.S. Children, Study Finds

Posted 8 Sep 2014 by Drugs.com

MONDAY, Sept. 8, 2014 – Although the overall rate of cancer in American children and teens remained stable during the last decade, rates of thyroid cancer and kidney cancer seemed to be on the rise, a new study says. The rate of thyroid cancer saw annual increases of nearly 5 percent and a specific type of kidney cancer, called renal carcinoma, had average increases of 5.4 percent per year, according to the study. The researchers also found that cancer rates among black children and teens increased 1.3 percent per year. But one doctor not involved with the study said the finding could be a statistical "fluke." "It's scary to see an increase, but these cancers are overall very rare and the increases very small," said lead researcher Dr. David Siegel, a pediatric hematology/oncology fellow at Children's Healthcare of Atlanta. "We don't want to give a message that's alarming," he said. ... Read more

Related support groups: Renal Cell Carcinoma, Thyroid Cancer

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Thyroid Disease

Related Drug Support Groups

Armour Thyroid, Nature-Throid, Nexavar, thyroid desiccated, Westhroid, doxorubicin, Adriamycin, Thyrogen, sorafenib, view more... Lenvima, vandetanib, NP Thyroid, lenvatinib, Cometriq, Caprelsa, Hicon, WP Thyroid, Thyroid Porcine, Adriamycin RDF, cabozantinib, thyrotropin alpha, Bio-Throid, sodium iodide-i-131, Iodotope, Adriamycin PFS